Neuropsychiatric manifestations of monkeypox: A clinically oriented comprehensive review

Yashendra Sethi1, Pratik Agarwal2, Hamsa Murli2

  • 1Department of Medicine, Government Doon Medical College, Dehradun, India.

Brain and Behavior
|April 12, 2023
PubMed

Insights

Monkeypox (MPX) outbreaks are linked to potential neuropsychiatric effects. This review highlights neurological and psychiatric complications, emphasizing the need for better case reporting to improve understanding and patient care.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Psychiatry

Background:

  • Monkeypox (MPX) outbreaks present evolving challenges to public health.
  • Orthopoxvirus family members, including MPX virus and its vaccine, are known to potentially cause neuropsychiatric effects.

Purpose of the Study:

  • To review current evidence on neuropsychiatric manifestations associated with MPX.
  • To underscore the importance of understanding evolving disease aspects and complications.

Main Methods:

  • A comprehensive literature review was conducted.
  • Recent evidence on MPX-related neuropsychiatric symptoms was compiled and analyzed.

Main Results:

  • Reported neurological complications include headaches, myalgia, encephalitis, and coma.
  • Psychiatric issues like anxiety and depression have been observed, though direct causality is not yet established.

Conclusions:

  • Enhanced reporting of MPX cases and adverse events is crucial.
  • Improved data will aid physicians in diagnosis, treatment, and informed decision-making.

Related Concept Videos

Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
202
Panic Disorder01:27

Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
160
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
288
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
628